139 related articles for article (PubMed ID: 22953636)
21. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
22. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
[TBL] [Abstract][Full Text] [Related]
23. A Greek survey of community prevalence and characteristics of constipation.
Papatheodoridis GV; Vlachogiannakos J; Karaitianos I; Karamanolis DG
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):354-60. PubMed ID: 19474747
[TBL] [Abstract][Full Text] [Related]
24. The impact of baseline intact parathyroid hormone levels on severity of primary hyperparathyroidism and outcomes in patients undergoing surgery.
Kandil E; Alabbas H; Tufaro AP; Carson KA; Tufano RP
Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):147-50. PubMed ID: 20157060
[TBL] [Abstract][Full Text] [Related]
25. Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism.
Feldstein CA; Akopian M; Pietrobelli D; Olivieri A; Garrido D
Clin Exp Hypertens; 2010 May; 32(3):154-8. PubMed ID: 20504122
[TBL] [Abstract][Full Text] [Related]
26. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
27. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
[TBL] [Abstract][Full Text] [Related]
28. Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism.
Pepe J; Magna A; Sonato C; Sgreccia A; Colangelo L; Occhiuto M; Cilli M; Minisola S; Cipriani C
J Endocrinol Invest; 2024 Jun; 47(6):1499-1504. PubMed ID: 38141155
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.
Tordjman KM; Yaron M; Izkhakov E; Osher E; Shenkerman G; Marcus-Perlman Y; Stern N
Eur J Endocrinol; 2010 May; 162(5):925-33. PubMed ID: 20421337
[TBL] [Abstract][Full Text] [Related]
30. Does hyperparathyroidism cause pancreatitis? A South Indian experience and a review of published work.
Jacob JJ; John M; Thomas N; Chacko A; Cherian R; Selvan B; Nair A; Seshadri M
ANZ J Surg; 2006 Aug; 76(8):740-4. PubMed ID: 16916398
[TBL] [Abstract][Full Text] [Related]
31. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of patients with raised serum calcium level in primary care, Sweden.
Dalemo S; Hjerpe P; Boström Bengtsson K
Scand J Prim Health Care; 2006 Sep; 24(3):160-5. PubMed ID: 16923625
[TBL] [Abstract][Full Text] [Related]
33. PTH inhibition rate is useful in the detection of early-stage primary hyperparathyroidism.
Zhao L; Zhang MJ; Zhao HY; Sun LH; Li JL; Tao B; Wang WQ; Ning G; Liu JM
Clin Biochem; 2011 Jul; 44(10-11):844-8. PubMed ID: 21524645
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of primary hyperparathyroidism in Europe.
Adami S; Marcocci C; Gatti D
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N18-23. PubMed ID: 12412773
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors for primary hyperparathyroidism in hyperthyroid patients.
Abboud B; Sleilaty G; Mansour E; El Ghoul R; Tohme C; Noun R; Sarkis R
Head Neck; 2006 May; 28(5):420-6. PubMed ID: 16388525
[TBL] [Abstract][Full Text] [Related]
36. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism.
VanderWalde LH; Liu IL; O'Connell TX; Haigh PI
Arch Surg; 2006 Sep; 141(9):885-9; discussion 889-91. PubMed ID: 16983032
[TBL] [Abstract][Full Text] [Related]
37. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
38. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
[TBL] [Abstract][Full Text] [Related]
39. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
[TBL] [Abstract][Full Text] [Related]
40. Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism.
Letizia C; Ferrari P; Cotesta D; Caliumi C; Cianci R; Cerci S; Petramala L; Celi M; Minisola S; D'Erasmo E; Mazzuoli GF
J Hum Hypertens; 2005 Nov; 19(11):901-6. PubMed ID: 16034450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
